High-Sensitivity Troponin I Assays: A Breakthrough in AMI Diagnosis

Diana Smith
Published on August 28, 2017
Cvd disease has been the leading cause of death worldwide for the last 15 years. Thanks to high-sensitivity troponin I assays, new possibilities have emerged for quicker, more accurate diagnoses of myocardial infarction.

Peter Kavsak, PhD, Associate Professor of Pathology and Molecular Medicine at McMaster University in Hamilton, Ontario, Canada

Chest pain is a common symptom of specific cvd diseases. The use of high-sensitivity troponin assays has the potential to change how patients with chest pain are triaged in the emergency department.

Taking aim at a global killer

Low levels of high-sensitivity troponin can rule out acute myocardial infarction with a single draw eliminating the need for serial measurements.

Faster rule-in/rule-out

Same protein, different reporting

Challenges for adoption

By Diana Smith
Diana Smith is a writer specializing in medical topics. She is based in Liberty Hill, Texas, USA.